Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00499187 · ClinicalTrials.gov registry record

Fanconi Syndrome Due to ARVs in HIV-Infected Persons

A clinical trial, sponsored by Gilead Sciences.

Completed
Registry status
56
Enrollment target

NCT00499187 is a clinical trial that has completed, run by Gilead Sciences. The registered enrollment target is 56 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00499187 has completed, sponsored by Gilead Sciences.

COMPLETED
Registry status
56 participants
Enrollment target

Study Summary

Cross-sectional cohort study of participants with HIV with or without protocol-defined Fanconi syndrome (confirmed creatinine clearance \[CLcr\] decline and evidence of proximal tubulopathy).

Interventions

  • PROCEDURE Blood Draws

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2007-09
Est. Completion 2011-03

Sponsor

Gilead Sciences

504 total trials

What the Registry Record Tells You About NCT00499187

The ClinicalTrials.gov registry entry for NCT00499187 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood Draws is the first listed.

NCT00499187 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00499187 about?

NCT00499187 is a clinical study titled "Fanconi Syndrome Due to ARVs in HIV-Infected Persons". Cross-sectional cohort study of participants with HIV with or without protocol-defined Fanconi syndrome (confirmed creatinine clearance \[CLcr\] decline and evidence of proximal tubulopathy).

What is the current status of trial NCT00499187?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2007-09. Estimated completion is 2011-03.

What interventions are being tested in trial NCT00499187?

The interventions under investigation include: Blood Draws (PROCEDURE).

Who is sponsoring clinical trial NCT00499187?

This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.